UC-Disease Activity Index | Download Table
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study | Gut
Metabolites | Free Full-Text | Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis | HTML
IBD Registry Web Tool User Guide
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild‐to‐moderate ulcerative colitis - Danese - 2019 - United European Gastroenterology Journal - Wiley Online Library
![PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3487ab107b3dfb52cb7dc2f7872fa75c27538395/5-Table4-1.png "PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar")
PDF] Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis | Semantic Scholar
Scores on Harvey Bradshaw Index (HB) and Ulcerative Colitis Disease... | Download Scientific Diagram
Inflammatory Bowel Disease | Clinical Gate
Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis - ScienceDirect
CDAI calculator (Crohn's Disease Activity Index)
Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods | Scientific Reports
Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis - Ma - 2018 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study | BMJ Open Gastroenterology
The Efficacy of the Consumption of n-3 Polyunsaturated Fatty Acids for the Maintenance of Remission in Patients with Inflammatory Bowel Disease
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology
Guidelines for the management of ulcerative colitis in the adult population (update)
Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
Inflammatory Bowel Disease | Clinical Gate
The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis - Clinical Gastroenterology and Hepatology
Cells | Free Full-Text | A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis
Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions - Clinical Gastroenterology and Hepatology
Cochrane
Diagnosis of acute severe colitis
Disease activity index (Schroeder and colleagues 14 ) | Download Table
